Literature DB >> 11782946

Integrin control of cell cycle: a new role for ubiquitin ligase.

Qing Qiu Pu1, Charles H Streuli.   

Abstract

Receptor tyrosine kinases and integrins are activated by growth factors and extracellular matrix, respectively. Their activation leads to signal transduction cascades that control many aspects of cell phenotype, including progression through the G(1) phase of the cell cycle. However, the signalling cassettes driven by growth factors and matrix do not work independently of each other. Integrin triggering is essential to facilitate kinase- and GTPase-mediated signals and thereby drive efficient transfer of information through the growth factor-cyclin axis. A recent study indicates that an additional type of player has a key role in adhesion-regulated control of cell cycle, namely ubiquitin ligase. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782946     DOI: 10.1002/bies.10049

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  4 in total

Review 1.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

Review 2.  Integrins and cell-fate determination.

Authors:  Charles H Streuli
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

3.  Effects of mutant human Ki-ras(G12C) gene dosage on murine lung tumorigenesis and signaling to its downstream effectors.

Authors:  Stephanie T Dance-Barnes; Nancy D Kock; Heather S Floyd; Joseph E Moore; Libyadda J Mosley; Ralph B D'Agostino; Mark J Pettenati; Mark Steven Miller
Journal:  Toxicol Appl Pharmacol       Date:  2008-04-27       Impact factor: 4.219

4.  Functionalized self-assembling peptide improves INS-1 β-cell function and proliferation via the integrin/FAK/ERK/cyclin pathway.

Authors:  Jingping Liu; Shuyun Liu; Younan Chen; Xiaojun Zhao; Yanrong Lu; Jingqiu Cheng
Journal:  Int J Nanomedicine       Date:  2015-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.